期刊文献+

ESSEN中风风险评估量表对预测缺血性脑卒中复发的价值 被引量:7

下载PDF
导出
摘要 目的:探讨ESSEN中分风险评估量表在预测缺血性脑卒中复发中的应用价值。方法:选择笔者所在医院2014年6月-2015年5月收治的205例缺血性脑卒中患者作为研究对象,按照ESSEN中风风险评估量表(ESRS)评分分为高危组(评分≥3分,n=100)与低危组(评分<3分,n=105),所有患者随访1年,观察复发情况。结果:所有患者随访1年,均未出现死亡,其中ESSEN中风风险评估高危组患者复发率高于低危组,差异有统计学意义(P=0.002);联合用药组的脑卒中复发率显著低于其他两组,差异有统计学意义(P<0.05)。高危组患者总不良事件发生率高于低危组,差异有统计学意义(X^2=8.008,P=0.004)。结论:ESSEN中风风险评估量表在预测缺血性脑卒中复发中具有重要意义,ESSEN评分越高则说明脑卒中复发风险越高,应采取有效预防措施,降低复发率,保障患者生存质量。
出处 《中外医学研究》 2018年第6期32-33,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 2016年钦州市科学研究与技术开发计划项目(项目编号:201614502)
  • 相关文献

参考文献2

二级参考文献30

  • 1Lowe HC,Oesterle SN,Khaehigian LM. Coronary in-stent restenosis :current status and future strategies[ J]. J Am Coll Cardiol,2002,39:183-193.
  • 2Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding anglographic pattern of restenosis after rapamycin-elufing stent implantation [ J ]. Circulation ,2003,108:257-260.
  • 3Lemos PA, Saia F, Ligthart JM, et al. Coronary restenosis after slrolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases [ J ]. Circulation, 2003,108:257-260.
  • 4Corbett SJ, Cosgrave J, Melzi G, et al. Patterns of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents [ J ]. Eur Heart J, 2006,27 (19) :2330- 2337.
  • 5Morice MC, Serruys PW, Barragan P, et al. Long-term clinical outcomes with sirolimus-etuting coronary stents :five-year results of the RAVEL trial[ J ]. J Am Coll Cardiol,2007,50(14) :1299-1304.
  • 6Weisz G,Leon MB,Holmes DR Jr,et al. Two-year outcomes after sirolimus-eluring stent implantation:results from the Sirolimus-Eluting Stent in de Novo N- ative Coronary Lesions (SIRIUS) trial [ J ]. J Am Coll Cardiot, 2006,47 ( 7 ) : 1350-1355.
  • 7Grube E,Silber S, Hauptmann KE, et al. TAXUS Ⅰ:sixand twelve-month resuits from a randomized, double-blind trial on a slow-release pactitaxel-eluting stent for de novo coronary lesions[ J]. Circulation ,2003,107( 1 ) :38-42.
  • 8Tanabe K, Serruys PW, Degertekin M. Chronic arterial responses to polymercontroned paclitaxel-eluting stents:comparison with bare metal stents by serial intravascular ultrasound analyses:data from the randomized TAXUS-Ⅱ trial [ J ]. Circulation, 2004,109 ( 2 ) : 196-200.
  • 9Ellis SG, Popma JJ, Lasala JM, et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation:analysis from the TAXUS-Ⅳ trial[ J]. J Am Coll Cardiol,2005,45 (8) :1193-1200.
  • 10Silber S. Cypher versus taxus:are there differences [ J ] ? J Interv Cardiol,2005, 18(6) :441-446.

共引文献14

同被引文献149

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部